Net sales of $1,698.3 million; increase of 4.6%; organic increase of 5.2%Diluted GAAP EPS of $0.30; adjusted EPS of $0.22Raised FY 2026 organic revenue growth, adjusted EPS and free cash flow guidanceRADNOR, Pa., Oct.
RADNOR, Pa., Oct. 26, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes
DENVER, Oct. 22, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) — Healthcare stocks are presenting investors with a mix of pharmaceutical growth stories and catalysts. Pfizer (NYSE:PFE) is drawing renewed attention to
RADNOR, Pa., Oct. 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release
RADNOR, Pa., Sept. 21, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints
Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4%Net income of $38.1 million; Adjusted EBITDA of $254.3 millionDiluted GAAP EPS of $0.06; adjusted EPS of $0.21Operating cash flow of $178.2
RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE:AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion
RADNOR, Pa., July 1, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced
RADNOR, Pa., May 19, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today
Net sales of $1,581 millionNet income of $43 million; Adjusted EBITDA of $219 millionDiluted GAAP EPS of $0.06; adjusted EPS of $0.17Operating cash flow of $59 million; free cash flow of $25 millionReaffirms FY 2026
RADNOR, Pa., April 23, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Avantor, Inc. (NYSE:AVTR) breached their fiduciary duties to
Portfolio now includes standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems for R&D through high-volume manufacturingCompany to attend INTERPHEX 2026 in New York City
St. Louis site strengthens integrated support for biopharma manufacturingRADNOR, Pa., April 13, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to
RADNOR, Pa., April 3, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced
